Jeffrey Rado is a Psychiatry physician affiliated with Northwestern University. OpenAlex indexes 54 publications with 596 citations (h-index 13); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
446 E Ontario St Ste 600
Chicago, IL 606117105
Telephone
312-695-5060Registry record last updated 1 May 2019.
Clinical trials
- COVID-19 & Psychiatry: A Retrospective Chart Review
Sponsor: Northwestern University
- Attitudes Towards Receiving Mental Health Care Using Telehealth During the Coronavirus Disease 2019 (COVID-19) Pandemic
Sponsor: Northwestern University
- Metformin for the Prevention of the Metabolic Side-effects of Zyprexa
Sponsor: Rush University Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202523 payments$26,652openpaymentsdata.cms.gov ↗
- Axsome Therapeutics, Inc.Program year202525 payments$19,919openpaymentsdata.cms.gov ↗
- Alkermes, Inc.Program year202519 payments$17,546openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
98%Atypical Antipsychotic25.7%Quetiapine Fumarate35%Clozapine22%Olanzapine21%Aripiprazole14%Invega Sustenna5%Ziprasidone Hcl4%Part D<11 patientsSSRI13.8%Fluoxetine Hcl34%Trazodone Hcl31%Sertraline Hcl18%Escitalopram Oxalate18%Part D<11 patients+ 13 more classes in this area
Cardiovascular
2%Beta blocker1.1%Propranolol Hcl100%Part D<11 patientsCalcium channel blocker0.9%Nifedipine Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Kuzel, MD
Northwestern University
Joel Charrow, MD
Northwestern University
Paul Cremer, MD
Northwestern University
Akhil Chawla, MD
Northwestern University
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”